BioCentury | Nov 12, 2020
Management Tracks

ObsEva, Korro bring in new CEOs; plus Cerebral, Spartan, Apnimed and Micronoma

...a board member. O’Callaghan was CEO of Petra Pharma Corp. Ram Aiyar joined RNA base editing company Korro Bio Inc....
...at DermTech Inc. (NASDAQ:DMTK). Danielle Golovin Aerpio Pharmaceuticals Inc. Nektar Therapeutics Spartan Bioscience Inc. ObsEva S.A. Cerebral Therapeutics Inc. Zogenix Inc. Xalud Therapeutics Inc. Micronoma Inc. Korro Bio Inc. Corvidia...
BioCentury | Sep 29, 2020
Finance

Data Bytes: strong year for series A rounds

...Korro Bio Inc. raised $91.5 million (see “NeoGene’s Series A”; “Korro Bio’s Series A”). Danielle Golovin Legend Biotechnology Co. Ltd. Korro Bio Inc. Neogene...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...Therapeutics Inc. (NASDAQ:BEAM) is also exploring RNA editing using the RNA-targeting Cas enzyme Cas13. Karen Tkach Tuzman Korro Bio Inc....
BioCentury | Dec 17, 2019
Emerging Company Profile

Triplet debuts with $59M, therapies for repeat expansion disorders

...founding CEO of CRISPR company Intellia Therapeutics Inc. (NASDAQ:NTLA) and co-founded RNA base editing company Korro Bio Inc....
BioCentury | Nov 21, 2019
Emerging Company Profile

ShapeTx: Shaping up RNA editing

...in as many months with an ADAR-based RNA editing technology, and NEA invested in both. Korro Bio Inc....
BioCentury | Oct 7, 2019
Emerging Company Profile

Gene editing vets launch Korro to convert RNA bases

...DNA damage repair pathways to treat repeat expansion disorders. Bermingham, who is executive chairman of Korro Bio Inc....
...is looking at the CNS, muscle, eye, ear and liver as potential targets. COMPANY PROFILE Korro Bio Inc....
Items per page:
1 - 6 of 6
BioCentury | Nov 12, 2020
Management Tracks

ObsEva, Korro bring in new CEOs; plus Cerebral, Spartan, Apnimed and Micronoma

...a board member. O’Callaghan was CEO of Petra Pharma Corp. Ram Aiyar joined RNA base editing company Korro Bio Inc....
...at DermTech Inc. (NASDAQ:DMTK). Danielle Golovin Aerpio Pharmaceuticals Inc. Nektar Therapeutics Spartan Bioscience Inc. ObsEva S.A. Cerebral Therapeutics Inc. Zogenix Inc. Xalud Therapeutics Inc. Micronoma Inc. Korro Bio Inc. Corvidia...
BioCentury | Sep 29, 2020
Finance

Data Bytes: strong year for series A rounds

...Korro Bio Inc. raised $91.5 million (see “NeoGene’s Series A”; “Korro Bio’s Series A”). Danielle Golovin Legend Biotechnology Co. Ltd. Korro Bio Inc. Neogene...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...Therapeutics Inc. (NASDAQ:BEAM) is also exploring RNA editing using the RNA-targeting Cas enzyme Cas13. Karen Tkach Tuzman Korro Bio Inc....
BioCentury | Dec 17, 2019
Emerging Company Profile

Triplet debuts with $59M, therapies for repeat expansion disorders

...founding CEO of CRISPR company Intellia Therapeutics Inc. (NASDAQ:NTLA) and co-founded RNA base editing company Korro Bio Inc....
BioCentury | Nov 21, 2019
Emerging Company Profile

ShapeTx: Shaping up RNA editing

...in as many months with an ADAR-based RNA editing technology, and NEA invested in both. Korro Bio Inc....
BioCentury | Oct 7, 2019
Emerging Company Profile

Gene editing vets launch Korro to convert RNA bases

...DNA damage repair pathways to treat repeat expansion disorders. Bermingham, who is executive chairman of Korro Bio Inc....
...is looking at the CNS, muscle, eye, ear and liver as potential targets. COMPANY PROFILE Korro Bio Inc....
Items per page:
1 - 6 of 6